BofA raised the firm’s price target on CareTrust REIT (CTRE) to $41 from $38 and keeps a Buy rating on the shares. While stock performance did not reflect it, Q3 earnings season was “strong” for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTRE:
- CareTrust REIT price target raised to $41 from $36 at RBC Capital
- CareTrust REIT Reports Strong Growth and Expansion
- CareTrust REIT Reports Strong Q3 2025 Results
- CareTrust REIT: Hold Rating Amid Revised Guidance and Strategic Investments
- CareTrust REIT announces series of transactions totaling $437M
